PHARMACEUTICAL INDUSTRY EXPANSION INTO BROADER HEALTH SECTORS LIKELY TO FACE LESS OVERSIGHT UNDER REPUBLICANS: BEGINNING OF ERA OF HEALTH CARE REFORGING?
Executive Summary
Glaxo's $5 mil. loan/investment in asthma clinics through Circadian, Inc. and J&J's agreement with the Nutri/System weight loss clinics are harbingers of the type of vertical merger activity that should accelerate throughout the health care field and particularly in the drug business with the Republican Congress virtually controlling antitrust oversight during the next two years.